CİNİSLİOĞLU, A. E. Et Al. 2024. Does Mirabegron the β3 Agonist Frequently Used in the Treatment of Overactive Bladder Really Affect the Respiratory System Negatively ? A Prospective Study. Recent Trends in Pharmacology .

CİNİSLİOĞLU, A. E., UTLU, A., AKSAKALLI, T., AKKAŞ, F., ÖZMEN, K., GEDİK, A., ... ARAZ, Ö.(2024). Does Mirabegron the β3 Agonist Frequently Used in the Treatment of Overactive Bladder Really Affect the Respiratory System Negatively ? A Prospective Study. Recent Trends in Pharmacology .

CİNİSLİOĞLU, AHMET Et Al. "Does Mirabegron the β3 Agonist Frequently Used in the Treatment of Overactive Bladder Really Affect the Respiratory System Negatively ? A Prospective Study," Recent Trends in Pharmacology , 2024

CİNİSLİOĞLU, AHMET E. Et Al. "Does Mirabegron the β3 Agonist Frequently Used in the Treatment of Overactive Bladder Really Affect the Respiratory System Negatively ? A Prospective Study." Recent Trends in Pharmacology , 2024

CİNİSLİOĞLU, A. E. Et Al. (2024) . "Does Mirabegron the β3 Agonist Frequently Used in the Treatment of Overactive Bladder Really Affect the Respiratory System Negatively ? A Prospective Study." Recent Trends in Pharmacology .

@article{article, author={AHMET EMRE CİNİSLİOĞLU Et Al. }, title={Does Mirabegron the β3 Agonist Frequently Used in the Treatment of Overactive Bladder Really Affect the Respiratory System Negatively ? A Prospective Study}, journal={Recent Trends in Pharmacology}, year=2024}